FindTrial
Sign In

Abberant expression of peripheral long noncoding RNA in mental disorder and its clinical application study

Abberant expression of peripheral long noncoding RNA in mental disorder and its clinical application study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-14005107
Enrollment
Unknown
Registered
2014-08-15
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disorder

Interventions

A:Positive symptomatology Group:medication
B:medication
C:medication
D:Anxiety disorder group:medication
E: Obsessive-compulsive disorder group:medication
F:Normal control group:observation
G: efficient group :medication
H: invalid group:medication
I: improved group :medication
J: improved group

Sponsors

No.102 hospital of Chinese People's Liberation Army, psychological disease prevention and control center of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: In accord with DSM-V; No history of blood transfusion one month before inclusion; No history of anti-psychotic medication three months before inclusion.

Exclusion criteria

Exclusion criteria: With history of brain trauma or other neurological diseases; With history of severe neurological dysfunction, affective disorder, or mental retardation; With history of severe alcoholic problem or drug abuse.

Design outcomes

Primary

MeasureTime frame
lncRNA;—

Countries

China

Contacts

Public ContactLi-yi Zhang
zly102@126.com+86 519-83064556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026